Exploring hepatitis C virus testing and treatment engagement over time in Melbourne, Australia: a study protocol for a longitudinal cohort study (EC-Experience Cohort study)

INTRODUCTION: The advent of direct acting antiviral therapy for hepatitis C virus (HCV) means the elimination of HCV is possible but requires sustained effort to achieve. Between 2016 and 2019, 44% of those living with HCV were treated in Australia. However, treatment uptake has declined significant...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Keefe, Daniel, Gunn, J, Ryan, Kathleen, Djordjevic, Filip, Kerr, Phoebe, Gold, Judy, Elsum, Imogen, Layton, Chloe, Chan, Kico, Dietze, Paul, Higgs, Peter, Doyle, Joseph, Stoové, Mark A, Hellard, Margaret, Pedrana, A E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728403/
https://www.ncbi.nlm.nih.gov/pubmed/34983773
http://dx.doi.org/10.1136/bmjopen-2021-057618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728403/
https://www.ncbi.nlm.nih.gov/pubmed/34983773
http://dx.doi.org/10.1136/bmjopen-2021-057618

Ejemplares similares